NCT00388609 - Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects | Biotech Hunter

Enrollment

705

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2009

Conditions

Obesity

Interventions

DRUG

BMS-646256

Tablet, Oral, Once Daily, 12 weeks treatment followed by 20 week washout (ST); up to 190 weeks treatment (LT)

DRUG

Placebo

Tablet, Oral, Once daily, 12 weeks treatment followed by 20 week washout (ST); up to 190 weeks treatment (LT)

Trial Locations (10)

Domenica M. Rubino, Md, Washington D.C.

National Clinical Research, Inc., Richmond

Hampton Roads Center For Clinical Research Inc., Norfolk

Duke University Medical Center, Durham

The Center For Nutrition & Preventive Medicine, Pllc, Charlotte

Medical University Of South Carolina, Charleston

Csra Partners In Health, Inc, Augusta

Springfield Diabetes And Endocrine Center, Springfield

Pennington Biomedical Research Center, Baton Rouge

Ucla Center For Human Nutrition, Los Angeles